Claritev Corp: Form 10-K for the period ended Dec 31, 2020
Filed with the SEC on Mar 16, 2021 and accepted by EDGAR at Mar 16, 2021, 16:14 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2020-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2020-10-01 to 2020-12-31 | $255.3m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 12 months2020-01-01 to 2020-12-31 | $937.8m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Operating income | 3 months2020-10-01 to 2020-12-31 | −$40.2m | us-gaap:OperatingIncomeLoss |
| Operating income | 12 months2020-01-01 to 2020-12-31 | −$131.8m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2020-01-01 to 2020-12-31 | $335.6m | us-gaap:InterestExpense |
| Income tax | 12 months2020-01-01 to 2020-12-31 | −$26.3m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2020-10-01 to 2020-12-31 | −$173.3m | us-gaap:NetIncomeLoss |
| Net income | 12 months2020-01-01 to 2020-12-31 | −$520.6m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2020-10-01 to 2020-12-31 | −$0.27 | us-gaap:EarningsPerShareBasicAndDiluted |
| Operating cash flow | 12 months2020-01-01 to 2020-12-31 | $377.4m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2020-01-01 to 2020-12-31 | $70.8m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 12 months2020-01-01 to 2020-12-31 | $101.1m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2020-12-31 | $126.8m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2020-12-31 | $208.9m | us-gaap:AssetsCurrent |
| Total assets | At period end2020-12-31 | $8.28bn | us-gaap:Assets |
| Current liabilities | At period end2020-12-31 | $112.5m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2020-12-31 | $5.73bn | us-gaap:Liabilities |
| Shareholders' equity | At period end2020-12-31 | $2.56bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001793229-21-000004. Last ingested by Listed: Nov 15, 2026, 00:46 ET. Listed shows no prices and gives no investment advice.